Teva to Present at BofA Securities Health Care Conference

Teva Pharmaceutical Industries Ltd., a global leader in the pharmaceutical industry, announced on May 4, 2026, that Eric Hughes will be a featured presenter at the BofA Securities Health Care Conference. Hughes, who holds the dual roles of Executive Vice President of Global R&D and Chief Medical Officer at Teva, is scheduled to deliver his remarks on Tuesday, May 12, 2026. The announcement was issued from the company's primary operational hubs in Parsippany, New Jersey, and Tel Aviv, Israel.^[1][2]

The presentation is officially scheduled to commence at 9:20 A.M. during the conference proceedings. Teva Pharmaceutical Industries maintains a significant market presence and is dual-listed for public trading on both the New York Stock Exchange and the Tel Aviv Stock Exchange under the ticker symbol TEVA. This upcoming appearance at the BofA Securities event highlights the company's ongoing engagement with the financial and healthcare investment communities following the formal notification of the speaking engagement.^[1][2]